Advanced Proteome Therapeutics (STU:0E81) Cyclically Adjusted Book per Share: €0.01 (As of Apr. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Advanced Proteome Therapeutics Cyclically Adjusted Book per Share?

Advanced Proteome Therapeutics STU:0E81 Cyclically Adjusted Book per Share is €0.01 as of Apr. 2023.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Advanced Proteome Therapeutics's adjusted book value per share for the three months ended in Apr. 2023 was €0.000. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.01 for the trailing ten years ended in Apr. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-31), Advanced Proteome Therapeutics's current stock price is €0.003. Advanced Proteome Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Apr. 2023 was €0.01. Advanced Proteome Therapeutics's Cyclically Adjusted PB Ratio of today is 0.30.


Advanced Proteome Therapeutics  (STU:0E81) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Advanced Proteome Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.003/0.01
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Advanced Proteome Therapeutics Cyclically Adjusted Book per Share Related Terms


Advanced Proteome Therapeutics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Advanced Proteome Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Proteome Therapeutics Cyclically Adjusted Book per Share Chart

Advanced Proteome Therapeutics Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.05 0.04 0.04 0.03

Advanced Proteome Therapeutics Quarterly Data
Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.03 0.04 0.04 0.01

STU:0E81 vs VRTX, REGN, SGEN: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Advanced Proteome Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Proteome Therapeutics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advanced Proteome Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Advanced Proteome Therapeutics's Cyclically Adjusted PB Ratio falls into.



Advanced Proteome Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Advanced Proteome Therapeutics's adjusted Book Value per Share data for the three months ended in Apr. 2023 was:

Adj_Book= Book Value per Share /CPI of Apr. 2023 (Change)*Current CPI (Apr. 2023)
=-0/123.5712*123.5712
=0.000

Current CPI (Apr. 2023) = 123.5712.

Advanced Proteome Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201307 0.002 97.261 0.003
201310 0.010 97.182 0.013
201401 -0.084 97.261 -0.107
201404 -0.021 98.920 -0.026
201407 0.040 99.315 0.050
201410 0.097 99.473 0.120
201501 0.094 98.209 0.118
201504 0.097 99.710 0.120
201507 0.133 100.579 0.163
201510 0.121 100.500 0.149
201601 0.112 100.184 0.138
201604 0.097 101.370 0.118
201607 0.089 101.844 0.108
201610 0.078 102.002 0.094
201701 0.079 102.318 0.095
201704 0.074 103.029 0.089
201707 0.047 103.029 0.056
201710 0.061 103.424 0.073
201801 0.019 104.056 0.023
201804 0.055 105.320 0.065
201807 0.030 106.110 0.035
201810 0.026 105.952 0.030
201901 0.033 105.557 0.039
201904 0.032 107.453 0.037
201907 0.028 108.243 0.032
201910 0.028 107.927 0.032
202001 0.024 108.085 0.027
202004 0.027 107.216 0.031
202007 0.009 108.401 0.010
202010 0.001 108.638 0.001
202101 0.006 109.192 0.007
202104 -0.024 110.851 -0.027
202107 -0.007 112.431 -0.008
202110 0.009 113.695 0.010
202201 0.026 114.801 0.028
202204 0.017 118.357 0.018
202207 0.026 120.964 0.027
202210 0.015 121.517 0.015
202301 0.008 121.596 0.008
202304 0.000 123.571 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €0.01 mean?
Advanced Proteome Therapeutics (STU:0E81) has a Cyclically Adjusted Book per Share of €0.01 as of Apr. 2023. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Advanced Proteome Therapeutics and its competitors.
Is Advanced Proteome Therapeutics' Cyclically Adjusted Book per Share too high?
Advanced Proteome Therapeutics' current Cyclically Adjusted Book per Share is €0.01.
How does Advanced Proteome Therapeutics' Cyclically Adjusted Book per Share compare to VRTX and REGN?
Advanced Proteome Therapeutics' Cyclically Adjusted Book per Share of €0.01 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Advanced Proteome Therapeutics and its competitors. Advanced Proteome Therapeutics's current Cyclically Adjusted Book per Share is €0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Proteome Therapeutics stock overvalued right now?
Advanced Proteome Therapeutics (STU:0E81) has a current Cyclically Adjusted Book per Share of €0.01. The current Cyclically Adjusted Book per Share is €0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Advanced Proteome Therapeutics (STU:0E81), the current Cyclically Adjusted Book per Share is €0.01 as of Apr. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced Proteome Therapeutics Business Description

Address 104 8337 Eastlake Drive, Burnaby, BC, CAN, V5A 4W2
Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.